Ginkgo biloba extract for improving thinking after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether taking a ginkgo biloba extract supplement can help improve thinking and memory after a recent stroke. People who participate will receive the extract and have their cognitive function assessed with simple tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a recent stroke (within the last 14 days) that is not a mini-stroke (TIA).
- You are 18 years or older.
- You can complete a simple thinking and memory test (score between 10 and 25 on the MoCA).
- You did not receive emergency clot-busting treatment (such as IV tPA or a procedure to remove the clot) when your stroke happened.
- You are not currently taking certain medications that affect thinking or mood (like antidepressants or memory drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a concentrated form of ginkgo, given soon after an ischemic stroke (a stroke caused by a blocked blood vessel), can help improve recovery. It's only for people who start treatment within 48 hours of symptoms, so timing is critical.
This study looks at thinking and memory problems in younger adults (18 to 45) who have had an ischemic stroke. It aims to understand how a stroke affects the brain's ability to think clearly.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
This trial tests whether sodium oligomannate can help prevent or lessen memory and thinking problems that can happen after a first stroke. It may help people who are recently hospitalized for ischemic stroke and have mild cognitive decline risk.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.